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1. Introduction 
Interferons are not only antiviral agents, but are 
also pleiotropic modifiers of cellular functions [ 1,2]. 
One aspect of IFN’s cellular activity, is its ability to 
inhibit normal and tumor cell proliferation [3]. In 
GO-arrested cells stimulated to grow by different 
mitogens, hormones or other positive growth-factors, 
IFN was reported to reduce the rate of cell entry into 
S-phase [4-71. In some cases, it also extended the 
S t G2 phases of the cell cycle [8,9]. Several observa- 
tions have led us to propose that the (2’-S’)-oligo- 
adenylate (oligo(A)) synthetase, which is induced in 
cells by IFN, is involved in the antimitogenic effects 
of IFN: First, (2’-5’)oligo(A) produces an antimito- 
genie effect when applied to intact lymphocytes 
stimulated by concanavalin A [lo]. Second, growth- 
related variations in the synthesis and degradation of 
(2’~S’)-oligo(A) were demonstrated [ 11,121. 
Here, we have extended the study of the anti- 
mitogenic effect of dephosphorylated (2’-5’)ApApA 
to serum-stimulated Balb/c 3T3 fibroblasts. Using a 
series of chemically synthesized derivatives of this 
oligonucleotide, we show that inhibition of DNA syn- 
thesis takes place only if the (2’-5’)-oligo(A) is at 
least 3 nucleotides long and has a free hydroxyl-group 
at the 5’-position. We show that the antimitogenic 
action results from a decrease in the rate of cell entry 
into S-phase. Finally, we present evidence that the 
antimitogenic activity of (2’-5’)ApApA is mediated 
by ribonuclease F (RNase F) activation [ 13,141 and 
a decrease in protein synthesis during the Cl phase of 
the cell cycle. 
2. Materials and methods 
2.1. Synchronization of Balb/c 3T3 jibroblasts 
Cells were grown in 30 mm plastic dishes at 37’C 
in 10% C&-humidified air, in Dulbecco’s modified 
Eagle’s medium (DMEM) with 10% calf serum. When 
confluent, cells were synchronized by incubation 24 h 
in DMEM without serum but containing 10% spent 
medium from the confluent cultures. These ‘serum- 
starved GO-arrested’ cells were transferred at time 0 to 
fresh medium with 10% calf serum, and IFN or (2’- 
5’)(Ap),A were added as indicated in the text. Cells 
from NIH 3T3 clone 1 [15] were synchronized in the 
same way. 
2.2.Measurement ofRNA and protein synthesis 
At different times after serum stimulation, the cul. 
tures were washed with DMEM and pulse-labeled for 
1 h with DMEM containing either [methyL3H] thy- 
midine (5 Ci/mmol, 10 &i/ml) or [35S]methionine 
(1260 Ci/mmol, 25 &i/ml) instead of cold methionine 
The (2’-5’)(Ap),A has to be removed from the cells 
before pulse labeling because it increases the incorpo- 
ration of thymidine and methionine into the acid- 
soluble pools. After labeling, the cells were washed 
with cold phosphate-buffered saline (PBS), precipi- 
tated with 5% trichloroacetic acid, treated with 0.1 N 
NaOH and the radioactivity was measured. [ 3H] Thy- 
midine-labeled cells were also fixed with glutaralde- 
hyde for autoradiography as in [Ill, and -800 cells/ 
dish were counted to calculate the labeling index. 
2.3. Preparation of (2’-5’)ApApA derivatives 
(2’-S’)(Ap),A dimers, trimers, and tetramers were 
chemically synthesized as in [ 161. For butyration 
[ 17 1, (2’-5’)ApApA tri-n-butylammonium salt 
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(50 pmol) was dissolved in 6 ml dimethylformamide 
(DMF). Butyric acid (500 pmol) was added, followed 
by dicyclohexylcarb odiimide (5 60 pmol) in 1 ml 
DMF. The reaction was kept at room temperature 
overnight, filtered and evaporated to dryness. The 
residue was extracted twice with 5 ml water, dissolved 
in DMF and added into ether. The precipitate was 
centrifuged, washed with ether and dessicated (yield 
62 mg). Butyrated (2’-5’)ApApA with a free 5’-OH 
was prepared as above, but starting with (2’-5’)- 
pApApA. The final product was treated with alkaline 
phosphatase to remove the 5’-phosphomonoester. 
The W spectrum (h,, 278 nm) indicated that the 
adenine ammo-groups were partially substituted. Pre- 
parative paper electrophoresis was used to separate 
the derivatives butyrated at the ammo-groups from 
those butyrated only on the ribose hydroxyl groups. 
For acetylation [ 18],1 ml acetic anhydride was 
added in 30 ~1 aliquots to 100 pmol(2’-5’)ApApA 
ammonium salt in 4 ml water, over 30 min while 
maintaining the pH at 7. with 4 N NaOH. The solution 
was concentrated to 4 ml, desalted on a BioGel P-2 
column (5 X 80 cm) in water and the nucleotide frac- 
tion waslyophilized. The W spectrum (h,, 258 nm) 
indicated that the adenines were not acetylated. The 
various compounds were purified before use by paper 
chromatography in butanol:acetic acid:water (5 :2:3, 
by vol.). The acetylated compound (2 in table 1) had 
a mobility of 3.1 relative to free (2’-5 ‘)ApApA vs 
4.1 for the fully butyrated derivative (5 in table 1). 
2.4. Materials 
Mouse L cell interferon partially purified to 10’ 
units/mg protein was prepared as in [ 191. Snake venom 
phosphodiesterase was from Worthington. All radio- 
active materials were from the Radiochemical Center, 
Amersham. 
3. Results 
3.1. Kinetics of the antimitogenic effect of (2’-5’)- 
ApApA in Balblc 3T3 cells 
Balb/c 3T3 cells synchronized in GO/G1 were 
serum-stimulated as in section 2. Fig.1 shows that 
addition of 50 PM (2’-5’)ApApA to the culture 
immediately after stimulation, inhibited the onset of 
DNA synthesis in the cell population as does IFN 
itself. At 5 PM, the oligonucleotide only delayed 
DNA synthesis. Measurement of the nuclear labeling 
index (insert of fig.1) showed that the inhibition of 
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Fig.1. Effect of (2’-5’)ApApA on DNA synthesis in serum- 
stimulated fibroblasts. Balb/C 3T3 cells were grown and syn- 
chronized as in section 2. Cells were stimulated with fresh 
medium plus 10% calf serum with no addition (e), with 5 PM 
or 50 PM (2’-5’)ApApA (A) or with 5OO/ml mouse L-cell 
interferon (0). At the indicated time intervals, cultures were 
washed and (in duplicates) pulse labeled 1 h with [methyl-‘HI- 
thymidine (5 Ci/mmol) to measure incorporation into DNA 
and for autoradiography. The labeling index (insert) was mea- 
sured by counting -800 cells. 
DNA synthesis actually represents a decrease in the 
number of cells entering into the S-phase. Next, the 
oligonucleotide was added at different times after 
serum addition (arrows in fig.2), and DNA synthesis 
was measured at 21 h. Maximal inhibition was 
obtained when (2’-5’)ApApA was added up to 5 h 
after stimulation (insert of fig.2). When added later, a 
gradual release from inhibition was observed, and no 
inhibition was seen if the nucleotide was added at 
17 h. The 5 h difference between the loss of inhibi- 
tion by IFN and by (2’-5’)ApApA (insert of fig.2) 
probably reflects the time which elapses between IFN 
binding to the cell and the intracellular response. 
Since (2’-5 ‘)ApApA does not inhibit DNA syn- 
thesis once it has been initiated, it is likely that the 
effect is not on DNA synthesis per se but rather on 
some events preceding entry into the S-phase. Fig.3 
shows that, indeed, the strong increase in the rate of 
protein synthesis which occurs from 8-20 h after 
serum addition and precedes the onset of DNA repli- 
cation, is abolished when (2’-5’)ApApA is present. 
During the first few hours, however, the rate of pro- 
tein synthesis is not affected by the oligonucleotide. 
Vesicular stomatitis virus replication measured by 
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Fig.2. Kinetics of release from the inhibitory effect of (2’-5’) 
ApApA on DNA synthesis. Balb/C 3T3 cells were treated as 
in tig.1, except that 50 FM (2’-S’)ApApA (A) or 500 U/ml 
mouse L-cell interferon (o) were added when indicated by 
arrows. The rate of DNA synthesis was measured at 21 h 
(insert); (0) control cells. 
Time after serum stimulation Wow.) 
20 
Fig.3. Effect of (2’-5’)ApApA on protein synthesis in serum- 
stimulated tibroblast. Balb/c cells were treated as in fig.1. 
(2’-5’)ApApA (10 PM) was added immediately after stimu- 
lation, and at different times the cultures were washed and 
pulse-labeled 1 h with [ 35S]methionine (25 &i/ml) as in 
section 2 to measure incorporation into protein. 
plaque assay, showed a 1 log inhibition in serum-stim- 
ulated 3T3 cells treated by 50 PM (2’-5’)ApApA 
(not shown). 
3.2. Structural requirements for the antirnitogenic 
activity of (2’-5’)ApApA 
In the serum-stimulated fibroblasts, (2’-5’) ApA 
dimers had little antimitogenic activity as compared 
to the trimer or tetramer (fig.4). Furthermore, the 
degradation products of (2’-S’)ApApA by snake 
venom phosphodiesterase, which include adenosine 
and AMP, had no antimitogenic activity in the con- 
centration range where (2’-5’)ApApA is active. This 
is an important control, since it eliminates a possible 
effect of adenosine on the cell [20]. To further ana- 
lyze the structural requirements, we assayed a series 
of substituted derivatives (table 1) for their ability to 
inhibit DNA synthesis in serum-stimulated 3T3 cells. 
Substitution of all ribose hydroxyl groups, by acetyla- 
tion or butyration, entirely abolished the activity 
(table 1, lines 2,3). In contrast, when the 5’-OH was 
protected during substitution (line 4) the inhibitory 
I I I I I 
10 20 30 40 50 
PM 
Fig.4. Antimitogenic effect of various (2’-5’)-oligo(A). 
Balb/c 3T3 cultures were synchronized as in section 2 and 
were treated with the different nucleotides at the time of 
serum addition. The rate of [‘HI thymidine incorporation 
was measured at 21 h for 1 h. Control cell value, 620 000 cpm. 
(A + PA) is the digestion product of (2’-5’)ApApA by snake 
venom phosphodiesterase. 
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Table 1 
Antimitogenic effect of various (2’-S’)ApApA derivatives in 
serum-stimulated fibroblasts 
Compound (10 PM) Inhibition of DNA synthesis 
1. Trimer 
2. Acetylated trimer, 
5’-blocked 
3. Butylated trimer, 
5’-blocked 
4. Butylated trimer ,
free 5 ‘-OH 
5. Butylated trimer, 
N-blocked 
Balb/c 3T3 cultures synchronized as in section 2, were treated 
with 10 PM of the different nucleotide derivatives at the 
time of serum addition. The rate of [3H]thymidine incorpo- 
ration was measured at 20 h for 1 h; control cell value, 
450 000 cpm 
activity was preserved. From these experiments we 
conclude that in the dephosphorylated (2’-S’)oligo-A, 
the 5’-OH must be free. Table 1 (line 5) also shows 
that substitution of the adenine amino groups in 
(2’-5’)ApApA leads to a complete loss of the anti- 
mitogenic activity. 
3.3. Resistance of a clone lacking RNase F to the 
an timitogenic effect of (2’-5’)ApApA 
In cell-free systems, (2’-5 ‘)ApApA inhibits protein 
synthesis by activating RNase F [ 13,141. In [ 151, 
NIH 3T3 clone 1 cells were resistant to IFN, probably 
because these cells lack RNase F activity. Fig.5 com- 
pares the effect of IFN and (2’-5 ‘)ApApA on DNA 
synthesis in Balb/c 3T3 and NIH 3T3 clone 1 cells, 
similarly synchronized and serum-stimulated. The 
NIH 3T3 clone 1 cells are clearly resistant to the anti- 
mitogenic effect of both IFN and the (2’-5’)ApApA. 
4. Discussion 
We have extended our studies on the antimitogenic 
effects of (2’-5’)oligo-A in lymphocytes [lo,1 l] to 
Interferon (U/ml) ,LLM l2’-5’) ApApA 
Fig.5. Comparison of the antimitogenic effect of (2’-5’)- 
ApApA and L-cell mouse interferon on Balb/c 3T3 cells and 
NIH 3T3 clone 1 cells. The cultures were grown and syn- 
chronized as in section 2 and treated with (2’-5’)ApApA 
or mouse L-cell interferon at the time of serum addition. The 
rate of [ 3H] thymidine incorporation was measured at 21 h 
for Balb/c cells (control value, 570 000 cpm) and at 19 h for 
NIH cells (control value, 370 000 cpm). In serum-starved 
cells incorporation was 600 and 3600 cpm, respectively. 
fibroblast undergoing transition from GO-G1 . This 
synchronous transition is markedly inhibited by IFN 
[8], and our results show that chemically synthesized 
(2’-5’)ApApA has a similar effect. The IFN-induced 
synthesis of (2’-5’)ApApA 1211 could, therefore, 
well be part of the molecular mechanism by which 
IFN inhibits cell growth. 
How does (2’-5’)ApApA inhibit cell mitogenesis? 
The simplest model would be through activation of 
RNase F as does the phosphorylated (2’-5’)pppApApA 
when introduced into permeabilized cells [22] or 
introduced by the calcium phosphate procedure [23]. 
In the latter system, there was an overall inhibition of 
protein, RNA and DNA synthesis as well as inhibition 
of virus replication [23]. We have used dephosphoryl- 
ated (2’-5’)ApApA because it can act on intact cells 
and produce a much more selective antimitogenic 
effect during GO-S transition, as well as an antiviral 
effect. Since the dephosphorylated oligonucleotide 
does not activate RNase F in cell-free systems [ 16, 
241, it could act either by being phosphorylated at 
the 5’-OH after entering the cell, or by some yet 
unknown mechanism. Our finding that a free 5’-OH 
in the oligonucleotide is essential for activity, supports 
the hypothesis that it becomes phosphorylated: The 
very low antimitogenic activity of the dimer, and the 
requirement for an intact adenine ring are also in 
line with a specific effect mediated by RNase F acti- 
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vation. Moreover, we now demonstrate that in serum- 
stimulated NIH 3T3 clone 1 cells [15], which are 
resistant to the antigrowth and antiviral effects of 
IFN because of a deficiency in RNase F, DNA synthe- 
sis is not inhibited by (2’-5’)ApApA. Provided that 
this is the only defect in these cells, this strongly indi- 
cates that RNase F is involved in the antimitogenic 
effect of (2’-S’)(Ap),A oligonucleotides. 
The antimitogenic effect of chemically synthesized 
(2’-5’)ApApA shows many similarities to that of 
IFN. In the 3T3 cell system described here, (2’-5’) 
ApApA extends the Gl phase and decreases the rate 
of cell entry into S as does IFN [8]. The antimitogenic 
effect of the nucleotide is preceded by a decrease in 
the overall rate of protein synthesis late in the Gl 
phase. We have detected by two-dimensional gel elec- 
trophoresis, a preferential inhibition in the synthesis 
of two proteins (69 000 and 76 000 M,) prior to the 
overall reduction in the rate of protein synthesis 
(unpublished). The antimitogenic effect could, there- 
fore, result from an inhibition in the synthesis of 
some specific proteins during Gl . In quiescent 
melanoma cells stimulated by serum, a possible role 
of the (2’-5’)oligo(A) synthetase in the antimito- 
genie effect of IFN was also suggested [23]. Thus, in 
lymphocytes, fibroblasts and even tumor cells, the 
transition of cells from quiescence to growth could 
involve a specific ‘restriction point’ in the Gl phase 
which is regulated by (2’-5’)oligo(A). If this hypoth- 
esis is correct, the antiviral and antimitogenic effect 
of IFNs would share a common molecular basis. 
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